A. Winges

发表

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

C. Miller, S. Frye, A. Tan, 2013, The Journal of clinical investigation.

LYMPHOID NEOPLASIA Mer receptor tyrosine kinase is a therapeutic target in pre – B-cell acute lymphoblastic leukemia

Kristen M. Jacobsen, A. Tan, H. Earp, 2013 .

Kristen M. Jacobsen, A. Tan, H. Earp, 2019, Encyclopedia of Biometrics.

Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia

D. DeRyckere, D. Graham, S. Christoph, 2013, Blood Cancer Journal.

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

C. Miller, S. Frye, J. M. Shields, 2013, The Journal of clinical investigation.